Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How ANGPTL3 Inhibition Will Help Our Clinical Practice?

Current atherosclerosis reports - 1 Jan 2023

Bini Simone, Tramontano Daniele, Minicocci Ilenia, Di Costanzo Alessia, Tambaro Federica, D'Erasmo Laura, Arca Marcello

Abstract excerpt

PURPOSE OF REVIEW: This review aims to summarize the most recently published literature highlighting the potential of pharmacological inhibition of ANGPTL3 in treating patients suffering from dyslipidemias. The rational for this strategy will be discussed considering evidence describing the role of ANGPTL3 in lipid metabolism and the consequences of its deficiency in humans. RECENT FINDINGS: Recent trials have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiopoietin-Like Protein 3
Share to Angiopoietin-like Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipid Metabolism

Share to Mutation

Source

Identifiers

PMID: 36607583
DOI: 10.1007/s11883-022-01076-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How ANGPTL3 Inhibition Will Help Our Clinical Practice?PMID 36607583Read ↗

ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases.Semantic proximity Read ↗

New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.Semantic proximity Read ↗

Familial combined hypolipidemia: angiopoietin-like protein-3 deficiencySemantic proximity Read ↗

Gene-based therapy in lipid management: the winding road from promise to practiceSemantic proximity Read ↗

ANGPLT3 in cardio-metabolic disorders.Semantic proximity Read ↗

ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief Report.Semantic proximity Read ↗

Recent developments in the genetics of LDL deficiency.Semantic proximity Read ↗

ANGPTL3 binds to PCSK9 to coordinately regulate intracellular lipid homeostasisSemantic proximity Read ↗

Angiopoietin-like 3 in lipoprotein metabolism.Semantic proximity Read ↗

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.Semantic proximity Read ↗

Selective Targeting of Angiopoietin-like 3 (ANGPTL3) with Vupanorsen for the Treatment of Patients with Familial Partial Lipodystrophy (FPLD): Results of a Proof-of-Concept StudySemantic proximity Read ↗

Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic riskSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.